Literature DB >> 27421860

Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication.

Vincent M Monnier1, Naoyuki Taniguchi2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27421860     DOI: 10.1007/s10719-016-9704-0

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


× No keyword cloud information.
  11 in total

1.  S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate.

Authors:  Nathan L Alderson; Yuping Wang; Matthew Blatnik; Norma Frizzell; Michael D Walla; Timothy J Lyons; Nadja Alt; James A Carson; Ryoji Nagai; Suzanne R Thorpe; John W Baynes
Journal:  Arch Biochem Biophys       Date:  2006-03-22       Impact factor: 4.013

2.  Chelation therapy: overlooked in the treatment and prevention of diabetes complications?

Authors:  Norma Frizzell; John W Baynes
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

Review 3.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

Authors:  J W Baynes; S R Thorpe
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

4.  N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.

Authors:  M U Ahmed; E Brinkmann Frye; T P Degenhardt; S R Thorpe; J W Baynes
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

5.  Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.

Authors:  M U Ahmed; S R Thorpe; J W Baynes
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

Review 6.  Role of oxidative stress in development of complications in diabetes.

Authors:  J W Baynes
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

Review 7.  Succination of proteins in diabetes.

Authors:  Norma Frizzell; Maria Lima; John W Baynes
Journal:  Free Radic Res       Date:  2010-10-22

8.  Chelating activity of advanced glycation end-product inhibitors.

Authors:  D L Price; P M Rhett; S R Thorpe; J W Baynes
Journal:  J Biol Chem       Date:  2001-10-24       Impact factor: 5.157

9.  Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications.

Authors:  Thomas O Metz; Nathan L Alderson; Mark E Chachich; Suzanne R Thorpe; John W Baynes
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

10.  Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.

Authors:  E B Frye; T P Degenhardt; S R Thorpe; J W Baynes
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  7 in total

Review 1.  Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.

Authors:  Alejandro Gugliucci
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

Review 2.  The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.

Authors:  Jyotiska Chaudhuri; Yasmin Bains; Sanjib Guha; Arnold Kahn; David Hall; Neelanjan Bose; Alejandro Gugliucci; Pankaj Kapahi
Journal:  Cell Metab       Date:  2018-09-04       Impact factor: 27.287

3.  Maillard reaction in vivo and its relevance to diseases: editorial and dedication.

Authors:  Motoko Takahashi; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2021-04-24       Impact factor: 2.916

Review 4.  The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.

Authors:  Chieh-Yu Shen; Cheng-Hsun Lu; Cheng-Han Wu; Ko-Jen Li; Yu-Min Kuo; Song-Chou Hsieh; Chia-Li Yu
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

Review 5.  Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis.

Authors:  Durai Sellegounder; Parisa Zafari; Misagh Rajabinejad; Mahdi Taghadosi; Pankaj Kapahi
Journal:  Int Immunopharmacol       Date:  2021-05-24       Impact factor: 5.714

6.  (R)-α-Lipoic acid inhibits fructose-induced myoglobin fructation and the formation of advanced glycation end products (AGEs) in vitro.

Authors:  Hardik Ghelani; Valentina Razmovski-Naumovski; Rajeswara Rao Pragada; Srinivas Nammi
Journal:  BMC Complement Altern Med       Date:  2018-01-15       Impact factor: 3.659

7.  Inhibitory Effects of Astaxanthin on CML-HSA-Induced Inflammatory and RANKL-Induced Osteoclastogenic Gene Expression in RAW 264.7 Cells.

Authors:  A N M Mamun-Or-Rashid; Tanzima Tarannum Lucy; Masayuki Yagi; Yoshikazu Yonei
Journal:  Biomedicines       Date:  2021-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.